View in EDS HTML Full Text PDF Full Text

Shifting the paradigm in personalized cancer care through next-generation therapeutics and computational pathology.

Saved in:
Bibliographic Details
Title: Shifting the paradigm in personalized cancer care through next-generation therapeutics and computational pathology.
Authors: Reis-Filho JS; Cancer Biomarker Development, Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Scaltriti M; Translational Medicine, Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Kapil A; Oncology Research and Development, AstraZeneca Computational Pathology GmbH, AstraZeneca, Munich, Germany., Sade H; Oncology Research and Development, AstraZeneca Computational Pathology GmbH, AstraZeneca, Munich, Germany., Galbraith S; Oncology Research and Development, AstraZeneca, Gaithersburg, Maryland, USA.
Source: Molecular oncology [Mol Oncol] 2024 Nov; Vol. 18 (11), pp. 2607-2611. Date of Electronic Publication: 2024 Aug 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39214683
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Shifting the paradigm in personalized cancer care through next-generation therapeutics and computational pathology.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Reis-Filho+JS%22">Reis-Filho JS</searchLink>; Cancer Biomarker Development, Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Scaltriti+M%22">Scaltriti M</searchLink>; Translational Medicine, Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kapil+A%22">Kapil A</searchLink>; Oncology Research and Development, AstraZeneca Computational Pathology GmbH, AstraZeneca, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Sade+H%22">Sade H</searchLink>; Oncology Research and Development, AstraZeneca Computational Pathology GmbH, AstraZeneca, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Galbraith+S%22">Galbraith S</searchLink>; Oncology Research and Development, AstraZeneca, Gaithersburg, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2024 Nov; Vol. 18 (11), pp. 2607-2611. <i>Date of Electronic Publication: </i>2024 Aug 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39214683
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.13724
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2607
    Titles:
      – TitleFull: Shifting the paradigm in personalized cancer care through next-generation therapeutics and computational pathology.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reis-Filho JS
      – PersonEntity:
          Name:
            NameFull: Scaltriti M
      – PersonEntity:
          Name:
            NameFull: Kapil A
      – PersonEntity:
          Name:
            NameFull: Sade H
      – PersonEntity:
          Name:
            NameFull: Galbraith S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1